Stroke patients treated at stem cell research centre

146

Stem cell research institute of STC Life and 97.7 B&H Clinic successfully completed mesenchymal stem cell treatment for stroke patients.

According to a press release, 97.7 B & H Clinic intravenously injected stem cells to stroke patients five times at intervals of two weeks. Mesenchymal stem cells, one of the adult stem cells, are widely used for tissue regeneration. Stem Cell Research Treatment Centre of STC Life gathered and used some stem cells from foetal umbilical cord.

Patients who received stem cell treatment significantly reduced the symptoms of paralysis such as speech impairment, and arms and legs paralysis. Also, the patients who were chair bound were able to walk without a walking frame after second treatment.

In addition, some patients’ language skills were improved by more than 90%. In the case of facial nerve paralysis, after three months treatment, some patients recovered their impairment by 80%. Some patients who had difficulty closing their eyes and speaking due to mouth droop could close their eyelids to 80% of their normal conditions, and the other patients have softened and eased movement of their lips after the treatment.

Also, some patient’s wrinkles around their mouth were flattened and some patients with dry mouth could facilitate movement of their faces. All of these improvements in symptoms were achieved with no side effects, the press release adds.

STC Life chairman, Kye Ho Lee, says: “We have been successfully carrying out stem cell therapy for the various diseases such as Parkinson’s disease, autoimmune disorders, anaemia, brain disorders, etc. Stem cells collected from STC Life Research Institute are known as adult stem cells that present in the body tissues and organs, thus maintaining the function of normal cells and the regeneration of damaged tissues in the human organs and enabling a variety of growth and differentiation in the human organs.”